British Journal of Dermatology. 177(6):1474–1475, DECEMBER 2017 DOI: 10.1111/bjd.16033 , PMID: 29313932 Issn Print: 0007-0963 Publication Date: December 2017 Print Brentuximab vedotin is an effective therapy for CD30+ mycosis fungoides and cutaneous anaplastic large-cell lymphoma: what is the cost? J. Scarisbrick; + Author Information 1University Hospital Birmingham, Birmingham, U.K. Checking for direct PDF access through Ovid Abstract Linked Article:Stranzenbach et al. Br J Dermatol 2017; 177:1503–1509.